Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-transplant Lymphoproliferative Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01075321
What this trial is testing

Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+16 more
Mayo Clinic 58
Early research (Phase 1)Ended earlyNCT01251952
What this trial is testing

Dose Escalation Trial of Denileukin Diftitox (Ontak) Post Autologous Transplantation

Who this might be right for
Multiple Myeloma
Barbara Ann Karmanos Cancer Institute 2
Early research (Phase 1)Study completedNCT01768338
What this trial is testing

Recombinant Human IL-18 and Ofatumumab After PBSCT for Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Michael John Robertson 9
Testing effectiveness (Phase 2)Looking for participantsNCT06686108
What this trial is testing

Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONRelapse
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 59
Not applicableUnknownNCT04489264
What this trial is testing

The Role of Consolidative Autologous Stem Cell Transplantation After First-line Therapy in Peripheral T Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Peking University 60
Large-scale testing (Phase 3)Active Not RecruitingNCT06045806
What this trial is testing

Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation

Who this might be right for
Multiple Myeloma
Celgene 79
Not applicableUnknownNCT05258136
What this trial is testing

Low-dose CD20 Monoclonal Antibody Injection in Preemptive Treatment of PTLD in Patients With EBV-HLH/CAEBV

Who this might be right for
PTLDCAEBVHLH
Beijing Friendship Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT03104491
What this trial is testing

Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

Who this might be right for
Acute Lymphocytic Leukemia
Leland Metheny 44
Testing effectiveness (Phase 2)Ended earlyNCT00240162
What this trial is testing

PTK/ZK as Post Transplant Maintenance Therapy in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 21
Post-approval studies (Phase 4)Looking for participantsNCT04989491
What this trial is testing

Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Received an EBV Seropositive Kidney Allograft

Who this might be right for
Epstein-Barr Virus Infections
University Hospital, Strasbourg, France 120
Testing effectiveness (Phase 2)Study completedNCT00530218
What this trial is testing

Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiableLeukemiaLymphoma+3 more
City of Hope Medical Center 61
Early research (Phase 1)Study completedNCT00729118
What this trial is testing

Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Neoplasm
Ohio State University Comprehensive Cancer Center 19
Large-scale testing (Phase 3)Active Not RecruitingNCT06475820
What this trial is testing

Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaBiphenotypic Acute Leukemia+2 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 150
Early research (Phase 1)Study completedNCT01087294
What this trial is testing

Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation

Who this might be right for
Leukemia, B-cellLymphoma, HodgkinsLymphoma, Non-hodgkins+1 more
National Cancer Institute (NCI) 85
Testing effectiveness (Phase 2)Looking for participantsNCT03970096
What this trial is testing

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+2 more
Fred Hutchinson Cancer Center 120
Large-scale testing (Phase 3)Looking for participantsNCT03562169
What this trial is testing

The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)

Who this might be right for
Multiple Myeloma
University of Leeds 406
Early research (Phase 1)Looking for participantsNCT06672705
What this trial is testing

Epcoritamab for the Treatment of Relapsed or Refractory Post Transplant Lymphoproliferative Disorders

Who this might be right for
Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative DisorderEBV-Related Post-Transplant Lymphoproliferative DisorderRecurrent Monomorphic Post-Transplant Lymphoproliferative Disorder+3 more
Timothy Voorhees
Not applicableStudy completedNCT03323541
What this trial is testing

Use of Zarzio® in Post-autologous Stem Cell Transplantation Procedure

Who this might be right for
Multiple MyelomaNon-hodgkin LymphomaHodgkin Lymphoma
University Hospital, Brest 62
Testing effectiveness (Phase 2)Looking for participantsNCT05805605
What this trial is testing

Allo HSCT Using RIC and PTCy for Hematological Diseases

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaBiphenotypic Acute Leukemia+15 more
Masonic Cancer Center, University of Minnesota 56
Testing effectiveness (Phase 2)UnknownNCT00048464
What this trial is testing

T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant

Who this might be right for
Multiple Myeloma
Xcyte Therapies 35
Next Page
26